CNE1000050F4
CNE1000050F4
SHANGHAI YIZHONG PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.61B EUR | 8.31B EUR | 11.78B EUR |
Enterprise Value | 7.23B EUR | 8.14B EUR | 11.64B EUR |
Valuation Multiples | |||
Trailing P/E | 108.24x | 103.84x | 168.15x |
Forward P/E | -- | -- | -- |
Price to Sales | 23.65x | 25.33x | 37.71x |
Price to Book | 5.46x | 5.57x | 8.13x |
EV/Revenue | 22.47x | 24.82x | 37.25x |
EV/EBITDA | 134.01x | 96.48x | 154.87x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -0.78% | -0.91% | -1.06% |